Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
about
Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytesStructural insights into the oligomerization mode of the human receptor for advanced glycation end-productsCirculating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and agingSoluble RAGE: a hot new biomarker for the hot joint?Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patientsS100A1: Structure, Function, and Therapeutic PotentialReceptor for advanced glycation end-products is a marker of type I cell injury in acute lung injuryVessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysisA crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosisO-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice.Troglitazone-induced changes in adiponectin do not affect endothelial function in diabetes.Tissue-advanced glycation end product concentration in dialysis patients.The Association of Serum Thrombomodulin with Endothelial Injuring Factors in Abdominal Aortic Aneurysm.Long-term successful weight loss improves vascular endothelial function in severely obese individuals.High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes.The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis.Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice.Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAHTriple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypesRAGE expression in human T cells: a link between environmental factors and adaptive immune responses.Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley ratsGlyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updateDifferential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.Meta-analysis of RAGE gene polymorphism and coronary heart disease riskAdvanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption.The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?Expression of receptor for advanced glycation end products in sarcoid granulomas.Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain.Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjectsType 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and functionReduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme.Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and FunctionCorticotropin releasing hormone and the skin.Adverse effects of hyperlipidemia on bone regeneration and strength.A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin.The relationships between atherosclerosis, heart disease, type 2 diabetes and dementia.Rho GTPases and leucocyte-induced endothelial remodelling.Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity
P2860
Q21994486-93DE9A2D-79AD-44BD-ACAA-4EB2B914AACCQ24338271-4FD88F5D-3B4D-4A4B-9032-E95D15063EAAQ24650528-DB6B14DC-E0FB-4D13-B9F5-36581115C4EDQ24817185-979F536C-E171-4FAA-85FC-CE7C42231406Q28218404-9FF5A942-9874-4BCA-978A-4749CB43EF09Q28263662-FD48CDF1-F627-42D8-8C09-EDB375B17828Q28566123-F1DC538D-F9EA-434C-83AD-12F67BCDA77EQ30484282-4B6DD22F-D34B-4DC1-B841-213DD1DF9BFCQ30535900-F6CDE08E-7B65-4CA8-B224-CE1392CD0A26Q30993051-2D21C05B-3756-41BE-88CF-5BD30017237FQ33220980-C84F8E70-B6A2-4DEC-9111-7D39F4A7AFCFQ33571288-57DDE010-5914-4747-A8BB-B09E87D41968Q33572127-46A6D364-E9C0-4397-9EC6-E981A98AC4F5Q33803736-8210E9C6-25A8-444A-9142-812F33ED266CQ33930928-84234D63-8EE8-42E5-949D-0F1A8C924CEBQ33940421-6EFFAFE8-9664-4E81-AC3D-EBF07D4F4DF7Q33950813-20D847D8-C211-45E4-9791-5017F8232FEDQ33999815-48B4C1E8-47A5-4DDF-9960-AD5172F981D4Q34133874-0386ECC5-8F3F-4949-B615-6F9E5A616787Q34221728-643E7081-471F-4A2D-B6E4-C1340D73288EQ34235391-D5C0CBF5-9DD8-48F9-A098-6DC20468ABC3Q34269548-162CE36C-7C89-429C-9583-878F4F0B9EFCQ34286094-E87C0C79-6D8C-4884-B043-E1F5B32F29F2Q34399952-B9674CA0-FCB3-4792-84A6-5494DA8568B6Q34448452-1830328E-58FC-4EF1-852E-AF02758394CEQ34510507-309C0DD3-CE54-4EBD-8D2B-F67C2E3BE370Q34542291-9870B47A-58D5-420D-9707-2E55C5B259BBQ34561697-B1870D96-D500-4544-83F4-D612D7CDBE4FQ34591271-62D9BCD1-C500-40E8-9F94-626EABCF9396Q35043454-A955B6BD-66FF-4C5E-88D0-EADA2ECD1270Q35083863-B86EB54E-1E2C-4205-AE1B-C64BB49EAF78Q35131581-DD8B90B6-63FC-4231-B7CF-64DD6595BB44Q35221896-61C96E38-4B98-44A6-BBF4-205FF24591B7Q35739011-D81A60BA-F643-4DBA-AA54-77CC672AF9C1Q35740745-CED626A7-B947-4256-9570-EC0B54D848D9Q35742748-A780DD2C-C73E-46A0-BE65-264E06CF84D7Q35752891-4920F7CA-D586-4EA6-9D8C-12426B22D892Q35841727-32970E50-3B7E-413E-AEB9-890432EF621EQ35923917-2EB6C35A-6011-4FB3-B141-31445CDAFE53Q36018253-8A10E8EA-E6F2-4470-994A-2F44F796AB5F
P2860
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@ast
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@en
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@nl
type
label
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@ast
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@en
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@nl
prefLabel
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@ast
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@en
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@nl
P2093
P1433
P1476
Glycation, inflammation, and R ...... ations of diabetes and beyond.
@en
P2093
Ann Marie Schmidt
Ravichandran Ramasamy
Shi Fang Yan
Yoshifumi Naka
P304
P356
10.1161/01.RES.0000103862.26506.3D
P577
2003-12-01T00:00:00Z